Skip to content
Disclosery

13F-HR filed by Darwin Global Management, Ltd.

Darwin Global Management, Ltd. filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 3 holding rows worth $611,701,341.

Accession
0001892688-23-000068
Filer
CIK 1839209
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 3 entries on the cover page, a total value of $611,701,341 stated on the cover page (in dollars after the unit check, H1), rows summing to $611,701,341 with VALUE read as dollars as filed, 13F file number 028-21006. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMBRX BIOPHARMA, INC. SPONSORED ADR02290A102COM16,688,636$274,694,949dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock9,278,439$230,476,425dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR273,343$106,529,967dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001892688-23-000068this filing2023-08-14acceptance time not in the bulk data set